Skip to main content
SpringerLink
Log in

Aminpräkursoren

  • Chapter
Neuro-Psychopharmaka Ein Therapie-Handbuch

  • 164 Accesses

Zusammenfassung

Störungen der Monoamin-Neurotransmitter Dopamin, Noradrenalin, Serotonin und Acetylcholin werden mit einer Vielzahl von psychiatrischen Krankheitsbildern in Verbindung gebracht. IJnter Aminpräkursoren versteht man die Vorläufer dieser Amine: L-Tryptophan, 5-Hydroxytryptophan, Phenylalanin, L-Tyrosin und Cholin (siehe Tabelle 10.1.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature

Literatur

  • BECKMANN H, ATHEN D, LTEANL M, ZIMMER R (1979) DL-phenylalanine versus imipramine: a double-blind controlled study. Arch Psychiat Nervenkr 227: 49-58

    PubMed  CAS  Google Scholar 

  • DEAKIN JF (1998) The role of serotonin in panic, anxiety and depression. Int Clin Psychopharmacol 13 [Suppl 4]: S1-5

    PubMed  Google Scholar 

  • DECTSCII SI, ROSSE RB, SchIwARTZ BL, BANAY SCIIWARTZ M, MCCARTHY MF, Jouai SK (1994) L-tyrosine pharmacotherapy of schizophrenia: preliminary data. Clin Neuropharmacol 17: 53-62

    Google Scholar 

  • GELENBERG AJ, WQJCIK JD, FALK WE, BAI.DESSARINI RJ, Zt:ISEI, SH, SCHOENEELD D, MoK GS (1990) Tyrosine for depression: a double-blind trial. J Affect Disord 19: 125-32

    PubMed  CAS  Google Scholar 

  • HEYMAN A, ScHMECHEL D, WILKINSON  W etal. (1987) Failure of long term high-dose lecithin to retard progression of early-onset Alzheimer's disease. J Neural Transm [Suppl] 24: 279-286

    CAS  Google Scholar 

  • Hotrokn NH, PEACE K (1994) The effect of tacrine and lecithin in Alzheimer's disease. A population pharmacodynamic analysis of five clinical trials. Eur J Clin Pharmacol 47: 17-23

    Google Scholar 

  • KILBOURNE EM, PHILEN KM, KAMB ML, FALK Il (1996) Tryptophan produced by Showa Denko and epidemic cosinophilia-myalgia syndrome. J Rheumatol [Suppll 46: 81-88

    CAS  Google Scholar 

  • KI.AASSEN T, KI.UMPERBEEK J, DEETZ NE, VAN PRAAC HM, GRIEZ  E (1998) Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res 77: 167-74

    Google Scholar 

  • McDoEGI.E CJ, NAYLOR ST, COHEN DJ, AGHAJANIAN GK, HENINGER GR, PRICI LH (1996) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53: 993-1000

    Google Scholar 

  • NEUMEISTER A, PRASCHAK RIEDER N, HESSELMANN B, Vrrouct i O, RAUH M, BAROCKA A, KAsIER S (1998) Effects of tryptophan depletion in fully remitted patients with seasonal affective disor- der during summer. Psychol Med 28: 257-264

    PubMed  CAS  Google Scholar 

  • RIEDE.L WJ, KLAASSEN T, DEt.TZ NF, VAN SoMEREN A, VAN PRA.kG HM (1999) Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology Berl 141: 362-369

    CAS  Google Scholar 

  • SMrru KA, FAIRBURN CG, CoweN PJ (1997) Relapse of depression after rapid depletion of tryptophan. Lancet 349: 915-919

    Google Scholar 

  • SMITH KA, FAIRBURN CG, CowEN PJ (1999) Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 56: 171-176

    PubMed  CAS  Google Scholar 

  • VAN PIAAG HM, KORF.J, DOI.S 1.C, SCHUT T (1972) A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia 25: 14-21

    Google Scholar 

Literatur

  • AGID Y, JAVOY F, GLOwINSKI J (1973) Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nature New Biology 245: 150-151

    PubMed  CAS  Google Scholar 

  • ALOUSI A, WEINER N (1966) The regulation of norepinephrine synthesis in sympathetic nerves: nerve stimulation, cocaine and catecholamine releasing agents. Proc Natl Acad Sci USA 56: 1491-1496

    PubMed  CAS  Google Scholar 

  • AMBROZI L, RIEDERER P, BIRKMAYER W, NEUMAYER E (1974) Zur Statistik des l'yrosin-l'ryptophanDiagramms hei der Depression. Dtsch Med Wochenschr 99 (20): 1087-1089

    PubMed  CAS  Google Scholar 

  • ASHCROFT GW, CRAWFORD TBB, ECCI.ESTON D, SHARMAN DF, MACDOUGALL EJ, STANTON JB, BINNs JK (1966) 5-I Iydroxyindole compounds in the cerebral fluid of patients with psychiatric or neurological disorders. Lancet ii: 1049

    Google Scholar 

  • AZORIN JM, SAMUELIAN-MASSAT C, JEANNINGROS R, WIDMER J, TISSOT R (1991) Erythrocyte membrane transports of monoemine precursor amino acids in schizophrenia. Encephale 17: 83-86

    PubMed  CAS  Google Scholar 

  • AZORIN JM, BovIER P, WIDMER J, TISSUE R, JEANNINGROS R (1992) Erythrocyte membrane transport of amino acid precursors of monoamines in schizophrenic patient. Comparison with depressive patients. Encephale 18: 585-590

    PubMed  CAS  Google Scholar 

  • BECKMANN H (1982) Biochemische Beiträge zu Klassifikation und Therapievorhersage bei endogenen Depressionen. In: BECKMANN H (I Irsg) Biologische Psychiatrie. Thieme, Stuttgart New York, S 126-147

    Google Scholar 

  • BIRKMAYER W, HORNYKIEWICZ O (1964) Weitere experimentelle Untersuchungen Ober L-Dopa beim Parkinson-Syndrom und Reserpin-Parkinsonismus. Arch Psychiat Z Ges Neurol 206: 606-607

    Google Scholar 

  • BRUINVELS J (1975) Role of sodium in neuronal uptake of monoamines and amino acid precursors. Nature 257: 606-607

    PubMed  CAS  Google Scholar 

  • BRUINVELS J (1980) Sodium ion displacement as a regulatory factor in depolarization-induced catecholamine biosynthesis. In: PARVez H, PARVEZ S (eds) Advances in experimental medicine: a centenary tribute to Claude Bernard. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 557-577

    Google Scholar 

  • BRUINVELS J (1981) Transport systems for tyrosine and their relation to catecholamine biosynthesis. In: Usoir E etal. ((Eds) Function and regulation of monoamine enzymes: basic and clinical aspects. McMillan, London Basingstoke, pp 315-326

    Google Scholar 

  • CANDITO M, AUBIN-BRUNET V, TONELLI I, FEUILLADE P, PRINGUEY D, CHAMBON P, DARCOURT G (1994) Plasma tryptophan in a protein controlled diet in depressed patients. Encephale 20: 327-332

    PubMed  CAS  Google Scholar 

  • CHIARONI P, AZORIN JM, BOVIER P, WIDMER J, JEANNINGROS R, BARRE A, DUFOUR H, TATOSSIAN A, TISSUE R (1990) A multivariate analysis of red blood cell membrane transports and plasma levels of L-tyrosine and L-tryptophan in depressed patients before treatment and after clinical improvement. Neuropsychobiology 23: 1-7

    PubMed  CAS  Google Scholar 

  • CORREN A, SHAW DM, FARRELL JP (1963) Potentiation of the antidepressant effect of a monoamine oxidase inhibitor by tryptophan. Lancet ii: 79-81

    Google Scholar 

  • Dn;z-GuERRA FJ, GIMENEZ C (1989) Nat-dependence of tyrosine transport across the synaptosomal membrane reflects changes in the morphology of synaptosomes. J Neurochem 52: 1366-1374

    Google Scholar 

  • EHRINGER H, HORNYKIEWICZ O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten hei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 38: 1236-1239

    PubMed  CAS  Google Scholar 

  • FERNSTROM JD (1979) Diet-induced changes in plasma amino acid pattern; effects on the brain uptake of large neutral amino acids, and on brain serotonin synthesis. 1 Neural Transm [Suppl] 15: 55-67

    CAS  Google Scholar 

  • FERNS'rRou JD, WURTMAN RJ (1971) Brain serotonin content: increase following ingestion of carbohydrate diet. Science 174: 1023-1025

    Google Scholar 

  • FERNSTROM JD, HIRSCH MJ, FALLER D (1976) Tryptophan concentrations in rat brain; failure to correlate with free serum tryptophan or its ratio to the sum of other serum neutral amino acids. Biochem J 160: 589-595

    PubMed  CAS  Google Scholar 

  • GooDWIN FK, COWDRY R, GOLD PW, WEI IR T (1977) Central monoamine metabolism in depression and mania. In: VAN PRAAG HM, BRUINVELS j(eds) Neurotransmission and disturbed behaviour. Bolin, Scheltema and Holkema, Utrecht, pp 34-59

    Google Scholar 

  • GRONIER B, JEANNINGROS R (1995) Kinetic characterization of a carrier-mediated transport system for L-tryptophan in human blood platelets. Int Clin Psychopharmacol 10: 95-101

    PubMed  CAS  Google Scholar 

  • HAMON M, BOURGOIN S, GLOWINSKI J (1974) Feed back regulation of 5-HT synthesis in rat striatal slices. J Neurochem 20: 1727

    Google Scholar 

  • HARPER AE, TEWS JK (1988) Nutritional and metabolic control of brain amino acids. In: HUETHER G (ed) Amino acid availability and brain function in health and disease. Springer, Berlin Heidelberg New York Tokyo, pp 3-12 (Nato ASI Series H, 20)

    Google Scholar 

  • JAQUIER E, LOVENBERG W, SJOERDSMA A (1967) Tryptophan hydroxylase inhibition: the mechanism by which pchlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 3: 274-278

    Google Scholar 

  • KNorr PJ, CURZON G (1972) Free tryptophan in plasma and brain tryptophan metabolism. Nature 239: 452-453

    Google Scholar 

  • LUCCA A, LI ICINI V, CATALANO M, SMERALDI E (1995) Neutral amino acid availability in two major psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 19: 615-626

    PubMed  CAS  Google Scholar 

  • MACKENZIE RG, TRULSON ME (1978) Does insulinact directly on the brain to increase tryptophan levels? J Neurochem 30: 1205-1208

    PubMed  CAS  Google Scholar 

  • MAES M, LIN AH, VERKERK R, DELMEIRE L, VAN GASTEL A, VAN DER PLANKEN M, SCHARPE S (1999) Serotonergic and noradrenergic markers of posttraumatic stress disorder with and without major depression. Neuropsychopharmacology 20: 188-197

    PubMed  CAS  Google Scholar 

  • MCGEER EG, PETERS DAV, MCGEER PL (1968) Inhibition of rat brain tryptophan hydroxylase by 6-halotryptophans. Life Sci 7: 605-615

    PubMed  CAS  Google Scholar 

  • Mc MENAMY RH, ONCLEYJL (1958) Specific binding of L-tryptophan to serum albumin. J Biol Chem 233: 1436-1447

    CAS  Google Scholar 

  • MEYERS S (2000) Use of neurotransmitter precursors for treatment of depression. Altern Med Rev 5: 64-71

    CAS  Google Scholar 

  • NAGATSU T, LEVITI M, UDENFRIEND S (1964) Tyro sine hydroxylase. J Biol Chem 239: 2910-2917

    PubMed  CAS  Google Scholar 

  • NEUMAYER E, RIEDERER P, DANIELCZYK W, SEEMANN D (1975) Biochemische Hirnbefunde hei endogener Depression. Wien Med Wochenschr 21: 344-349

    Google Scholar 

  • OLDENDORF WH (1971) Brain uptake of radio-labeled amino acids, amines and hexoses after arterial injection. Am J Physiol 221: 1629-1639

    PubMed  CAS  Google Scholar 

  • RIEDERER P, BIRKMAYER W (1993) Pathobiochemie bei Depressionen. 1. Alle Defizitmodelle sind heute überholt. Ärztl Praxis 45 (14): 27-29

    Google Scholar 

  • RIEDERER P, BIRKMAYER W (1993) Pathobiochemie bei Depressionen. 2. Ungleichgewicht zwischen den Überträgersystemen? Ärztl Praxis 45: 26-30

    Google Scholar 

  • SEDVALL GC, KOPIN IJ (1967) Acceleration of nor-epinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation. Life Sci 6: 45-51

    PubMed  CAS  Google Scholar 

  • TAGLIAMONTE A, BIGGIO G, GESSA GL (1971) Possible role of free plasma tryptophan in controlling brain tryptophan concentration. Riv Farmacol Terapia 2: 251-255

    CAS  Google Scholar 

  • TAGLIAMONTE A, BIGGIO G, VARGUI L, GESSA GL (1973) Free tryptophan in serum controls brain tryptophan level and serotonin synthesis. Life Sci 12: 277-287

    CAS  Google Scholar 

  • UDENFRIEND S, SALTZRLAN-NIRENBERG P, NAGATSU T (1965) Inhibition of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol 14: 837-845

    PubMed  CAS  Google Scholar 

  • VAN PRAAG HM (1981) Management of depression with serotonin precursors. Biol Psychiatry 16: 291-310

    PubMed  CAS  Google Scholar 

  • VAN PRAAG HM, KORE J, PUTTE J (1970) 5-hydro-xyindolcacetic acid in the cerebrospinal fluid. of depressive patients treated with probenecid. Nature 225: 1259-1260

    Google Scholar 

  • WADE LA, KATZMAN R (1975) Synthetic amino ac- ids and the nature of L-DOPA transport at the blood brain harrier. J Neurochem 25: 837-842

    PubMed  CAS  Google Scholar 

  • WEINER N (1970) Regulation of norepinephrine biosynthesis. Ann Rev Pharmacol 10: 273-290

    PubMed  CAS  Google Scholar 

  • WEINER N, BJUR R, LEE FL, BECKER G, MOSIMANN F (1973) Studies on the mechanism of regulation of tyrosine hydroxylase activity during nerve stimulation. In: UsDIN E, SNYDER S (eds) Frontiers in catecholaminc research. Perga-mon Press, New York, pp 211-221

    Google Scholar 

  • WILKINSON LS, COLLARD KJ (1984) Opposite effects of extracellular sodium removal on the uptake of tryptophan into rat cortical slices and synaptosomes. J Neurochem 43: 274-275

    PubMed  CAS  Google Scholar 

  • WURTMAN RF, LARIN F, MOSrAFAPOUR S, FERNSTROM JD (1974) Brain catechol synthesis: control by brain tyrosine concentration. Science 185: 183-184

    CAS  Google Scholar 

  • YOUNG SN (1996) Behsvioral effects of dietary neurotransmitter precursors: basic and clinical aspects. Neurosai Biobehav Rev 20: 313-323

    Google Scholar 

  • YOUNG SN, CIIOUINARD G, ANNABLE L, MORAND C, ERVIN FR (1984) The therapeutic action of tryp- tophan in depression, mania and aggression.In: SCHLOSSBERGER HG, KOCHEN W, LINZEN B, STEINHART H (eds) Progress in tryptophan and serotonin research. Gruyter, Berlin New York, pp 321-324

    Google Scholar 

  • ZIGMOND J, ABERCROMBIE ED, BERGER TW, GRACE AA, STRICKER EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. TINS 13: 290-296

    PubMed  CAS  Google Scholar 

Literatur

  • ANGST J, WOGGON B, Scrrorii J (1977) The treatment of depression with 1-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study. Arch Psychiat Nervenkr 224: 175-186

    PubMed  CAS  Google Scholar 

  • AYLWARD M (1976) Presented on a meeting of the Royal College of Physicians

    Google Scholar 

  • ANONYMOUS (1989) Eosinophilia-myalgia syndrome. New Mexico Morbid Mortal Wkly Rep 38: 765-767, 785

    Google Scholar 

  • BARKER A, Scorn J, EccjEstoN D (1987) The Newcastle chronic depression study: results of a treatment regime. Int Clin Psychopharmacol 2: 261-272

    PubMed  CAS  Google Scholar 

  • BARLET P, PALIARD P (1974) Etude clinique du 5hydroxytryptophane dans les etats depressifs du troisieme age. Cah Med Lyonnais 50: 1895-1901

    Google Scholar 

  • BECKMANN H, KASPER S (1983) Serotonin-Vorstufen als Antidepressiva. Eine Übersicht. Fort-sehr Neurol Psychiat 51: 176-182

    CAS  Google Scholar 

  • BELONGIA EA, HEDBERG CW, GLEICH GJ, WHITE KE, MAYENO AN, LOEGRING DA, DUNETTE SL, PIRIE PL, MACDoNALD KL, OSTERHOLM MT (1990) An investigation of the cause of the eosinophiliamyalgia syndrome associated with tryptophan use. N Engl J Med 323: 357-365

    Google Scholar 

  • BOMAN B (1988) L-Tryptophan: a rational antidepressant and a natural hypnotic? Aust NZ J Psychiatry 22: 83-97

    Google Scholar 

  • BRODIE HKH, SACK R, SIEVER L (1973) In: BARCIIAS J, LSDIN E (eds) Serotonin and behavior. Academic Press, New York, pp 549-559

    Google Scholar 

  • BUNNEY WE, BRODIE HKH, MURPHY DL, GOODWIN FK (1971) Studies of a-methyl-p-tyrosine, L-dopa, and L-tryptophan in depression and mania. Am J Psychiatry 127: 872-881

    PubMed  CAS  Google Scholar 

  • CHAMBERLAIN B, ERVIN FR, PIHL RO, YOUNG SN, (1987) The effect of raising or lowering tryp- tophan levels on aggression in velvet mon- keys. Pharmacol Biochem Behav 28: 503-510

    PubMed  CAS  Google Scholar 

  • CHOUINARD G, YOUNG SN, ANNABLE L, SOURKES TL (1979) Tryptophanicotinamide, imipramine and their combination in depression. Acta Psychiatr Scand 59: 395-414

    PubMed  CAS  Google Scholar 

  • CHOUINARD G, YOUNG SN, ANNABLE L (1985) Acontrolled clinical trial of L-tryptophan in acute mania. Biol Psychiatry 20: 546-557

    PubMed  CAS  Google Scholar 

  • COLE JO, HARTMAN E, BRIGH_AM P (1980) L-tryptophan: clinical studies. In: COLE JO (ed) Psychopharmacology update. The Collamore Press, Lexington, pp 119-148

    Google Scholar 

  • CONTE HR, PLLTCHIK R (1974) Personality and background characteristics of suicidal mental patients. J Psychiat Res 10: 181

    PubMed  CAS  Google Scholar 

  • COPPEN A, SHAW DM, FARREL JP (1963) Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet i: 78-81

    Google Scholar 

  • COPPEN A, SHAW DM, HERZBERG R, MAGGS R (1967) Tryptophan in the treatment of depression. Lancet ii: 1178-1180

    Google Scholar 

  • COPPEN AJ, PRANGE JR AJ, WHYBROW PC, NOGUERA R (1972) Abnormalities of indoleamines in affective disorders. Arch Gen Psychiatry 26: 474-478

    PubMed  CAS  Google Scholar 

  • DUNNER DL, FIEvE RR (1975) Affective disorder: studies with amine precursors. Am J Psychiatry 132: 180-183

    PubMed  CAS  Google Scholar 

  • FARINELLI S et al. (1991) Sindrome eosinofilia-mialgia associata a 5-OH-triptofano descrizione di un caso. Recenti Progressi in Medicina 82: 7-8

    Google Scholar 

  • FARKAS T, DUNNER DL, FIEVE RR(1976) L-Tryptophan in depression. Biol Psychiatry 11: 295-302

    PubMed  CAS  Google Scholar 

  • GLASSMAN AH, PLATTMAN SB (1969) Potentiation of a monoamine-oxidase inhibitor by tryptophan. J Psychiatr Res 7: 83-88

    PubMed  CAS  Google Scholar 

  • HERRINGrON RN, BRUCE A, JOHNSTONE EC (1976) Comparative trial of L-tryptophan and amitriptylin in depressive illness. Psychol Med 6: 673-678

    Google Scholar 

  • JENSEN K, FRUENSGAARD K, AHLFORS UG (1975) Tryptophan/Imipramine in depression. Lancet 9: 920

    Google Scholar 

  • KIRKEGAARD C, MOLLER SE, Bjorn IMN (1978) Addition of L-tryptophan to electroconvulsive treatment in endogenous depression. A double-blind study. Acta Psychiatr Scand 58: 457-462

    PubMed  CAS  Google Scholar 

  • KLINE NS, SACKS W (1963) Relief of depression within one day using an MAO inhibitor and intra-venous 5-HTP. Am J Psychiatry 120: 274-275

    PubMed  CAS  Google Scholar 

  • KLINE NS, SACKS W (1980) Treatment of depression with an MAO inhibitor followed by 5HTP — an unfinished research project. Acta Psychiatr Scand [Suppl 2801: 233-241

    Google Scholar 

  • LINDBERG D, AHLFORS LTG, DENCKER SJ (1979)Symptom reduction in depression after treatment with L-tryptophan or imipramine. Acta Psychiatr Scand 60: 287-294

    Google Scholar 

  • LOPEZ-IBOR AJJ, GUTTERREZ I, INGLESIAS M (1973) Tryptophan and amitriptyline in the treatment of depression. hit Pharmacopsychiatry 8: 145-151

    Google Scholar 

  • LOPEZ-IBOR JJ, GUTIERREZ JJA, IGLESIAS MLMM (1976) 5-hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depression. A double-blind controlled study. Int Pharmacopsychiatry 11: 8-15

    Google Scholar 

  • MENDELS J, STINNEr JL, BURNS D, FRAZER A (1975) Amine precursors and depressions. Arch Gen Psychiatry 32: 22-30

    PubMed  CAS  Google Scholar 

  • MENDLEWICZ J, YounIM MBH (1980) Antidepressant potentiation of 5-hydroxytryptophan by L-deprenyl in affective illness. J Affect Dis 2: 137-146

    PubMed  CAS  Google Scholar 

  • MURPHY DL, BAKER M, GOODWIN FK, MILLER II, KoTIN JR, BUNNEY WE (1974) L-Tryptophan in affective disorders. Indoleamine changes and differential clinical effects. Psychopharmacology 34: 11-20

    CAS  Google Scholar 

  • NEUMEISTER A, PRASCHAK-RIEDER N, HESSELMANN B, TAUSCHFR J, KASPER S (1997) Der Tryptophan-depletionstest — Grundlagen and klinische Relevanz. Nervenarzt 68: 556-562

    PubMed  CAS  Google Scholar 

  • NARDINI M, DE STEFANO R, LANNUCCELLI M, BORGHESI R, BATTISTININ N (1983) Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study. Int J Clin Pharm Res 111: 239-250

    Google Scholar 

  • POPE HE, JoNAS JM, HUDSON JI (1985) Toxic reactions to the combination of monoamineoxidase inhibitors and tryptophan. Am J Psychiatry 142: 491-492

    PubMed  Google Scholar 

  • PRAAG HM v (1978) Psychotropic drugs. A guide for the practitioner. Brunner/Mazel, New York, pp 280-281

    Google Scholar 

  • PRAAG HM v (1984) Studies in the mechanism of action of serotonin precursors in depression. Psychopharmacol Bull 20: 599-602

    PubMed  Google Scholar 

  • PRAAG IM V, KoRF J (1971) Endogenous depression with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification? Psychopharmacologia 19: 148-152

    Google Scholar 

  • PRAAG HM v, DE HAAN S (1980) Depression vulnerability and 5-hydroxytryptophan prophylaxis. Psychiatry Res 3:75-83

    Google Scholar 

  • PRAAG HM V, KORF J, Dots LCW, SCHUT T (1972) Apilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as an antidepressant. Psychopharmacology 25: 14-21

    Google Scholar 

  • QUADBECK H, LEHMANN E, TEGELE R (1984) Comparison of the antidepressant action of tryptophan, tryptophan/5-hydroxytryptophan combination and nomifensine. Neuropsychobiology 11: 111-115

    PubMed  CAS  Google Scholar 

  • RALEIGH MJ (1987) Differential behavioral effects of tryptophan and 5-hydroxytryptophan in vervet monkeys: influence of catecholaminergic systems. Psychopharmacology 93: 44-50

    PubMed  CAS  Google Scholar 

  • Rao B, BROADHURST AD (1976) Tryptophan and depression. Br Med J 1: 460

    PubMed  CAS  Google Scholar 

  • RAOTMA H (1978) Has tryptophan any anticonvulsive effect? Acta Psychiatr Scand 57: 253-258

    PubMed  CAS  Google Scholar 

  • DE SMET PAGM (1991) Drugs used in non-orthodox medicine. In: DuKEs MNG, ARONSON JK (eds) Side effects of drugs, annual 15. Elsevier, Amsterdam, pp 514-531

    Google Scholar 

  • SOURKSS TL (1983) Toxicology of serotonin pre- cursors. Adv Biol Psychiatry 10: 160-175

    Google Scholar 

  • THOMAS JM, RUBIN EH (1984) Case report of a toxic reaction from a combination of tryptophan and phenelzine. Am J Psychiatry 141: 281-283

    PubMed  CAS  Google Scholar 

  • TuomsoN J, RANKIN H, ASHCROFr GW, YATES CM, MCQUEEN JK, CUMMINGS SW (1982) The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. Psychol Med 12: 741-751

    Google Scholar 

  • WALINDER J (1983) Combination of tryptophan with MAO inhibitors, tricyclic antidepressants and selective 5-HT reuptake inhibitors, Biol Psychiatry 10: 82-93

    Google Scholar 

  • WALLNDE RJ, SKOTT A, NAGY A (1976) Potentiation of antidepressant action of clomipramine by tryptophan. Arch Gen Psychiatry 33: 1384-1389

    Google Scholar 

  • WEISSMAN M, Fox R, KLERMAN JL (1973) Hostility and depression associated with suicide attempts. Am) Psychiatry 130: 450

    CAS  Google Scholar 

  • WILLErr M, PRASCHAK-RIEDER N, NEUMEISTER A, PIRKER W, VITOUCH O, ASENBAUM S, BRÜCKE T, TAUSCHER J, KASPER S (2000) (1231)13-C1T SPECT imaging shows reduced brain serotonin transporter availability in drug free depressed patients with seasonal affective disorder. Biol Psychiatry 47: 482-489

    Google Scholar 

  • WOERr VAN MH, ROSENBAUM D, HOWIESON J, BOWERS MB (1977) Long-term therapy of myoclonus and other neurologic disorders with L5-hydroxytryptophan and carbidopa. N Engl J Med 296: 70-75

    Google Scholar 

  • WORRAI. FP, MODDY JP, BEET M, DICK P, SMITH A, CHAMBERS C, ADAMS M NAYLOR GJ (1979) Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry 135: 255-262

    Google Scholar 

  • WURTMAN RJ, HEITI F, MHLAMED E (1981) Precursor control of neuro-transmitter synthesis. Pharmacol Rev 32: 315-335

    Google Scholar 

  • YOUNG SN (1986) The clinical psych opharmacology of tryptophan. In: WURTMAN RJ, WURTMAN JJ (eds) Nutrition and the brain, vol 7. Raven, New York, pp 49-88

    Google Scholar 

  • ZIPP F, DEMISCH L (1992) Aktuelles in der Diskussion um das Eosinophilie-Myalgie-Syndrom (EMS). Nervenarzt 63: 249-253

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. Bandelow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Rüther
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Bruinvels
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Riederer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Kasper
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Neurochemie, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universität Würzburg, Bundesrepublik Deutschland

    Peter Reiderer

  2. Bezirksklinikikum Gabersee, Ludwig-Maximilians-Universität München, Wasserburg a. Inn, Bundesrepublik Deutschland

    Gerd Laux

  3. Wien, österreich

    Walter Pöldinger

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag/Wien

About this chapter

Cite this chapter

Bandelow, B., Rüther, E., Bruinvels, J., Riederer, P., Kasper, S. (2002). Aminpräkursoren. In: Reiderer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka Ein Therapie-Handbuch. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6150-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6150-0_10

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83647-7

  • Online ISBN: 978-3-7091-6150-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation